Recent advances in metabolic engineering of Escherichia coli for riboflavin biosynthesis
World Journal of Microbiology and Biotechnology · 2025-10 · 41 (10)
DOI: 10.1007/s11274-025-04563-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift World Journal of Microbiology and Biotechnology, online erschienen am 26.09.2025. Verfasst von Shuang Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Bioengineering, Zhejiang University of Technology, 310014, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Metabolic Engineering, Escherichia coli, Riboflavin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Scientific Research Starting Foundation of Zhejiang University of Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
Escherichia coli has emerged as a promising microbial platform for industrial riboflavin (RF) biosynthesis, enabled by systematic metabolic engineering of its well-characterized genetic system. This minireview synthesizes key strategies for enhancing RF production, focusing on: (i) Precursor optimization through reinforced pentose phosphate pathway flux (elevating ribulose-5-phosphate) and deregulated purine biosynthesis (boosting GTP availability); (ii) Pathway engineering via rib operon overexpression coupled with feedback inhibition relief through ribF modulation and FMN riboswitch deletion; (iii) Competitive flux minimization by redirecting carbon from acetate formation and catabolic side-reactions; and (iv) Cellular robustness enhancement through NADPH/ATP cofactor balancing and stress tolerance engineering. Complementary bioreactor parameter control including defined media formulations, temperature profiling, and dynamic pH/dissolved oxygen regulation has proven critical for translating laboratory-scale genetic improvements to high-titer production. Recent advances in CRISPR-based genome editing, multi-omics-guided pathway optimization, and antibiotic-free plasmid stabilization demonstrate E. coli's growing viability as a sustainable RF cell factory, with future progress hinging on integrated systems metabolic engineering approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, 310014, Hangzhou, Zhejiang, China.
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, 310014, Hangzhou, Zhejiang, China. sundch@zjut.edu.cn.
Förderung
- Scientific Research Starting Foundation of Zhejiang University of Technology
- National Natural Science Foundation of China
Zitieren
APA
Liu, S., & Sun, D. (2025). Recent advances in metabolic engineering of Escherichia coli for riboflavin biosynthesis. World Journal of Microbiology and Biotechnology, 41(10). https://doi.org/10.1007/s11274-025-04563-9
Vancouver
Liu S, Sun D. Recent advances in metabolic engineering of Escherichia coli for riboflavin biosynthesis. World Journal of Microbiology and Biotechnology. 2025;41(10). doi:10.1007/s11274-025-04563-9
BibTeX
@article{Liu2025,
author = {Liu, Shuang and Sun, Dongchang},
title = {Recent advances in metabolic engineering of Escherichia coli for riboflavin biosynthesis},
journal = {World Journal of Microbiology and Biotechnology},
year = {2025},
volume = {41},
number = {10},
doi = {10.1007/s11274-025-04563-9}
}
EUVIMED